Home / Health / J&J Robotic Surgery Device Gets FDA Nod
J&J Robotic Surgery Device Gets FDA Nod
22 Jul
Summary
- FDA approved Johnson & Johnson's robotic surgery device.
- Ottava system cleared for various upper abdomen surgeries.
- J&J plans a U.S. commercial launch for the device.
Johnson & Johnson announced on Wednesday that the U.S. Food and Drug Administration has granted marketing authorization for its innovative robotic surgery device. This significant approval allows the healthcare giant to officially enter the competitive soft-tissue robotic surgery market.
The Ottava robotic surgical system has received clearance for use in a range of general surgery procedures targeting the upper abdomen. These include critical operations such as gastric bypass, gastrectomy, gallbladder removal, gastric sleeve surgery, appendectomy, and hiatal hernia repair.
Johnson & Johnson stated that it will initiate a U.S. commercial launch of the Ottava system with a select group of customers. The company also indicated its ongoing efforts to expand the system's indications and introduce it into additional regulatory markets globally.
